Nuclear Medicine Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Report ID: GMI3205

  Table of Contents
Summary Methodology

Nuclear Medicine Market size is projected to experience significant growth from 2019 to 2025.
 

Rising prevalence of cancer will be a key factor in nuclear medicines market growth. According to National Cancer Institute, in 2016, there were about 15.5 million cancer survivors in the United States. The number of cancer survivors is expected to reach 20 million by 2026. As per World Health Organization (WHO) study, globally about 1 in 6 deaths is due to cancer. Increasing incidences of cancer patients across the globe is expected to boost the demand for nuclear medicine market.
 

Sedentary lifestyle has been a major cause of cardiovascular diseases in the world. Cardiovascular diseases continue to be the leading cause of deaths worldwide. According to WHO, the number of deaths due to cardiovascular diseases is expected to reach 24 million by 2030. Rising number of cardiovascular diseases due to surge in the number of cigarette smokers and diabetes patients will further fuel the nuclear medicines market growth.
 

However, stringent government regulatory framework could pose a hurdle to the nuclear medicines market growth. Risks associated with exposure to radiations coupled with high costs could stagnate the growth further.
 

Single Photon Emission Computed Tomography (SPECT) has witnessed considerable technological advancements in the recent years. For instance, improved cameras and computer-aided image enhancement have bolstered the SPECT scanning market growth. Technological advancements coupled with reduced costs will drive the SPECT market growth substantially.
 

Brachytherapy is gaining momentum due to the several advantages it offers. The radiation is delivered with a high level of accuracy and has a minimized risk of side effects. It also has proven to be a good alterative for surgery and chemotherapy in cancer treatment. Other advantages such as reduced costs and shorter recovery time are expected to boost brachytherapy market growth.
 

Number of cancer patients have increased substantially in the recent years. Advancements in radiation therapies have increased cure rate in cancer patients. For instance, in the treatment of prostate cancer, brachytherapy has higher cure rate as compared to chemotherapy or surgery. Surge in the number of cancer patients coupled with advancements in cancer treatment will significantly drive the nuclear medicine market growth.
 

U.S. is expected to dominate the global nuclear medicine market during the forecast period. Availability of advanced healthcare infrastructure coupled with increase in healthcare spending will substantially drive the nuclear medicine market growth in the U.S.  Furthermore, majority of players are present in U.S. that will lead to development of advanced products, thus leading to market growth in the region.  
 

Some of the prominent players of global Nuclear Medicines market include Bayer AG, Bracco Diagnostic Inc., Cardinal Health, Curium Pharma, GE Healthcare, Koninklijke Philips N.V., Lantheus Medical Imaging, Inc., Medtronic, NTP Radioisotopes SOC Ltd. and Siemens Healthineers. The competitors focus on product launch, merger and acquisitions to strengthen market position.
 

Nuclear medicine market, by diagnostics, 2014-2025 (USD Million)

  • SPECT
  • PET

Nuclear medicine market, by therapeutics, 2014-2025 (USD Million)

  • Alpha Emitters
  • Beta Emitters
  • Brachytherapy

Nuclear medicine market, by application, 2014-2025 (USD Million)

  • Oncology
  • Cardiology
  • Neurology
  • Orthopedics
  • Thyroid
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

Company Profiles:

  • Bayer AG
  • Bracco Diagnostic Inc.
  • Cardinal Health
  • Curium
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Lantheus Medical Imaging, Inc.
  • Medtronic
  • NTP Radioisotopes SOC Ltd.
  • Siemens Healthineers

What Information does this report contain?

Historical data coverage: 2014 to 2018; Growth Projections: 2019 to 2025.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.


Customize this Report

15% Free Customization
Share your Requirements

Customize this Report

Special Requests?

Inquire Before Buying
This site is protected by Trustwave's Trusted Commerce program Authorize.Net Merchant - Click to Verify BBB Rating - Click to Verify

Questions? Speak to an Analyst

Full Name *
Email *
Phone (With Country Code)
Message *
Are you human?
0 + 1 =

Your personal details are secure. Privacy Policy

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

Connect with our sales team

Chat With Us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info. I Agree